Another report on metastatic melanoma [7] described downregulation of HLA-A expression in biopsies of progressing lesions compared to pre-treatment ones in 4 of 18 melanoma patients receiving ICI therapy [7]. The gene discussed is HLA-A; the disease is melanoma.